Automate Your Wheel Strategy on HLVX
With Tiblio's Option Bot, you can configure your own wheel strategy including HLVX - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol HLVX
- Rev/Share 0.0
- Book/Share 3.0194
- PB 0.7054
- Debt/Equity 0.1593
- CurrentRatio 25.3184
- ROIC -0.5962
- MktCap 106800466.0
- FreeCF/Share -1.8082
- PFCF -1.1817
- PE -0.9996
- Debt/Assets 0.1344
- DivYield 0
- ROE -0.6133
- Rating B-
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 4
- P/B Score 5
- D/E Score 2
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| No ratings available. | |||||||
News
HilleVax (HLVX) Upgraded to Strong Buy: What Does It Mean for the Stock?
HLVX
Published: July 11, 2025 by: Zacks Investment Research
Sentiment: Positive
Published: July 11, 2025 by: Zacks Investment Research
Sentiment: Positive
HilleVax (HLVX) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Read More
About HilleVax, Inc. (HLVX)
- IPO Date 2022-04-29
- Website https://www.hillevax.com
- Industry Biotechnology
- CEO Robert M. Hershberg
- Employees 14
HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company is headquartered in Boston, Massachusetts.